Exciting Innovations Await at the 31st Annual Congress of the European Society of Gene and Cell Therapy. We are thrilled to announce that our company will be attending the 31st Annual Congress of the European Society of Gene and Cell Therapy (ESGCT) in Rome, Italy from October 22nd-25th, 2024. PhoenixBio is excited to be sponsoring a booth and attending the the annual meeting to get the latest updates in the fast moving field of gene and cell therapy! Meet with our team at Booth #B18 to learn more about PhoenixBio's capabilities and how our humanized liver mouse model and fresh human hepatocytes provide an unparalleled translational platform to advance your studies.
This premier event brings together leading researchers, industry experts, and clinicians from around the globe to discuss the latest advancements in gene and cell therapy.
At ESGCT, we look forward to engaging with thought leaders and innovators who are shaping the future of this rapidly evolving field. Our team is eager to share our recent breakthroughs in gene editing research tools and animal models to evaluate the development of novel therapies aimed at treating genetic disorders. We believe that collaboration is key to advancing scientific knowledge, and events like this provide an invaluable platform for exchanging ideas and forging partnerships.
Throughout the congress, we will be presenting our latest research tools and showcasing our innovative solutions designed to enhance translational research outcomes. We invite attendees to visit our booth, where our experts will be available to discuss our projects, answer questions, and explore potential research collaborations.
As we prepare for this exciting event, we are reminded of the profound impact that gene and cell therapies can have on patients’ lives. Together, we can push the boundaries of science and make significant strides in transforming healthcare.
Join us at ESGCT 2024 as we celebrate innovation, collaboration, and the promise of a healthier future. Stay tuned for updates and insights from the congress!